1
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
Condition(s):Opioid-Related DisordersLast Updated:March 26, 2018Completed
Nalmefene as an Intervention: 31 Clinical Trials, Page 1 of 4
Hide Studies Not Open or Pending
2
Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects
Condition(s):Renal ImpairmentLast Updated:November 8, 2016Completed
3
Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia
Condition(s):ResuscitationLast Updated:October 6, 2022Recruiting
4
Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge
Condition(s):Alcohol DependenceLast Updated:November 11, 2014Completed
5
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
Condition(s):Alcohol DependenceLast Updated:December 14, 2016Completed
6
Evaluation of Nalmefene in Impulse Control Disorders in Parkinson’s Disease: A Prospective Open Label Study
Condition(s):Impulse Control Disorders; Parkinson DiseaseLast Updated:October 17, 2016Unknown status
7
Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity
Condition(s):AlcoholismLast Updated:July 2, 2017Terminated
8
Patient Driven Recovery With Nalmefene and Coaching
Condition(s):Opioid-use Disorder; Harmful; Use, AlcoholLast Updated:January 22, 2021Completed
9
Pharmacokinetic Evaluation of Intranasal Nalmefene
Condition(s):PharmacokineticsLast Updated:October 22, 2021Completed
10
Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
Condition(s):Opioid OverdoseLast Updated:December 12, 2022Completed